INGEN FILES THIRD QUARTER REPORT
-The Company Gains Traction With Sales and a NewGovernment Contract-Yucaipa, CA, April 7, 2011: IngenTechnologies, Inc. (OTC Markets: IGNT.OTC), an ISO 13485:2003 certified medicaldevice manufacturer of respiratory medical devices announced today that thecompany has filed their third quarter report ending February 28, 2011 on theOTC Markets News and Disclosure Service.
The companyreported a sales increase of 221% compared to sales in the quarter endedFebruary 28, 2010. The sales in the current quarter were fueled by the newIngen Pulse Oximeter. These salesaccounted for 83.6% of the current quarter sales.
The companyreceived a Department of Veterans Affairs Federal Supply Scheduled ContractAward beginning on April 1, 2011 and ending on March 31, 2016. A Contract AwardLetter was received from the VA National Acquisition Center on March 24, 2011.The company was provided a copy of the Federal Supply Schedule ContractV797P-4379b, effective April 1, 2011 through March 31, 2016, for items awardedunder 65IIA under the Medical Equipment and Supplies Federal Supply ScheduleSolicitation 797-FSS-99-0025-R6.
"We are focused on purchase orders through our new contractaward with GSA. We also expect to receive approval with the Defense AcquisitionProgram Administration to sell our medical technology to military and defensefacilities worldwide. The company and its management are looking forward to asuccessful year." Stated Gary Tilden, Chairman and Chief Operationsofficer.
AboutIngen:
The Public Company's wholly owned subsidiary is an established ISOcertified medical device manufacturer with an emerging new medical product linefor the respiratory market worth an estimated $4 Billion in the US, and $8billion globally. Visit www.ingen-tech.com.
Safe Harbor for Forward-Looking Statements: This news releaseincludes forward-looking statements. While these statements are made toconvey to the public the company’s progress, business opportunities and growthprospects, readers are cautioned that such forward-looking statements representmanagement’s opinion. Whereas management believes such representations tobe true and accurate based on information and data available to the company atthis time, actual results may differ materially from those described. Thecompany’s operations and business prospects are always subject to risk anduncertainties. Important factors that may cause actual results to differare and will be set forth in the company’s periodic filings withthe U.S. Securities and Exchange Commission.